Table 3.
Prognostic value of MCT expression in human cancers.
| Cancer type | High MCT1 | High MCT2 | High MCT4 | Ref. |
|---|---|---|---|---|
| Adrenocortical carcinoma | good | [152] | ||
| Bladder cancer | poor | Uncertain | [154], [220], [221] | |
| Breast cancer | poor | poor | [196], [223], [224], [225] | |
| Clear renal cell cancer | poor | poor | [227], [230] | |
| Colorectal cancer | poor | [231] | ||
| Glioblastoma | poor | [203] | ||
| Head and neck cancer | poor | [162], [232] | ||
| Hepatocellular carcinoma | good | poor | [31] | |
| Lung cancer | poor | [193], [196] | ||
| Melanoma | poor | poor | [96], [159] | |
| Neuroblastoma | poor | [188] | ||
| Osteosarcoma | poor | [80] | ||
| Ovarian Cancer | poor | poor | [182] | |
| Prostate cancer | poor | [35], [93] | ||
| Soft tissue sarcoma | poor | poor | [36] | |
| Testicular germ cell cancer | poor | poor | [164] |